- Home
- BTI vs SNY Comparison
BTI vs SNY Comparison
Compare BTI & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTI | SNY |
|---|---|---|
| Founded | 1902 | 1994 |
| Country | United Kingdom | France |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.8B | 104.5B |
| IPO Year | 2004 | 2001 |
Fundamental Metrics
Financial Performance| Metric | BTI | SNY |
|---|---|---|
| Price | $56.17 | $44.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $62.00 | $58.00 |
| AVG Volume (30 Days) | ★ 4.1M | 2.8M |
| Earning Date | 02-12-2026 | 04-23-2026 |
| Dividend Yield | ★ 5.51% | 3.47% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.72 | $3.49 |
| Revenue Next Year | $3.56 | $6.10 |
| P/E Ratio | $12.53 | ★ $6.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $49.88 | $40.89 |
| 52 Week High | $67.30 | $52.68 |
Technical Indicators
Market Signals| Indicator | BTI | SNY |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 53.26 |
| Support Level | $55.67 | $43.28 |
| Resistance Level | $62.93 | $45.22 |
| Average True Range (ATR) | 0.76 | 0.52 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 31.40 | 55.13 |
Price Performance
Historical ComparisonAbout BTI British American Tobacco Industries p.l.c. ADR
The third-largest tobacco company by volume, British American Tobacco sold 465 billion cigarettes in 2025. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.